Children as young as six have been treated for cannabis addiction in Manchester, a drugs expert has said.

Drug specialists also reported regularly seeing addicts aged eight and nine referred to them.

They said the children suffered from paranoia, sleeplessness, anxiety, depression and schizophrenia.

One drugs worker said the youngest child he had dealt with was six - and that addiction was usually just one of a series of problems youngsters face.

Mike Linnell, 47, from the charity Lifeline Project , which has run a support service for young substance abusers in Manchester for two years, said: “We run eight different young person’s services in the country and two years ago we didn’t run any.

“Around 70% of the young people who we treat come to us through the criminal justice service.

“They have mostly been in trouble with the law already and drug addiction is only one of a whole series of problems they have to face.”

Oldham Alcohol Substance Intervention Service (Oasis) said children were trying out drugs at a younger age.

The warning comes only days after a new study into the effects of cannabis led to calls for the government to reclassify the drug.

Oasis opened five years ago and offers support to young people suffering drug abuse problems.

Jamelia Rashid, from the centre, said: “It is very unusual to have a child as young as eight suffering from cannabis addiction.

“We have only had one case of a child of that age coming to us within the last five years.

“Alcohol, not cannabis, remains the most commonly abused drug among young people.

Ms Rashid added: “The average age for young people seeking support for problematic cannabis use is around 14, though it’s not unusual for 11 and 12-year-olds to begin experimenting”.

He added that many of these children also have family problems, alcohol addiction and are frequently in care.

Via BBC News

STUDY: Two popular Diabetes drugs may double the risk of heart failure
Two popular drugs used to treat late-onset diabetes may double the risk of heart failure, according to a new study. Researchers who analysed data on 78,000 patients who took Avandia or Actos to treat type II diabetes found that it increased the risk of heart failure by up to 100 percent, said the study released on Thursday.
Read more: What’s New?

Color in Science: Is My Blood Really Blue?
You probably learned your basic human anatomy sometime around grade school. Textbooks said your blood was red and a scraped knee on the playground confirmed it. We bleed red because of hemoglobin, an iron-containing protein that carries oxygen throughout the body. So… Why Are My Blood Veins Blue?
Read more: Color in Science: Is My Blood Really Blue?

6 Canned Foods You Should Never Try!
With hurricane season almost upon us, it ’s time to start stocking up on bottled water, extra batteries and canned food. But why stick to just beans and corn? Here’s a look at some more exotic (read: disugusting!) canned foods we found.
Read more: 6 Canned Foods You Should Never Try!

Is sea salt better for you than regular salt?
The main thing sea salt has going for it is happy vibes. Salt mines have long been proverbial sites of drudgery. In contrast, you rarely hear anyone gripe about having to get back to the beach.
Read more: Is sea salt better for you than regular salt?

Blueberries reduce colon cancer risk by 57%, animal study finds
A compound found in blueberries shows promise of preventing colon cancer, according to a new study. Scientists at Rutgers University and the U.S. Department of Agriculture conducted a joint study on animals, and found that the compound, called pterostilbene, lessened pre-cancerous lesions and inhibited genes involved in inflammation.
Read more: Blueberries reduce colon cancer risk by 57%, animal study finds

British scientists pioneer TB vaccine
The first vaccine against tuberculosis to be developed for 80 years has begun clinical trials. If the tests are successful, it could be available within eight years, giving medicine an important weapon for containing the resurgent disease.
Read more: British scientists pioneer TB vaccine